Substance P (SP) is a neuropeptide widely distributed in the nervous system. Its release within the bone marrow (BM) can mediate bidirectional neurohematopoietic communication via specific receptors: neurokinin-1R (NK-IR), NK-PR, or NK-BR. We have previously reported that SP effects on hematopoiesis are mediated by an NK-l-type receptor, the BM stroma, and growth factors. Here, we have studied the induction of stem cell factor (SCF) and interleukin-l (IL-l) by SP in stroma. At lo-' mol/L SP, cytokine levels in supernatants were IL-la, 20 & 5 ng/mL; IL-1p.40 f 10 ng/mL; and SCF, nondetectable; and the cell-associated levels were SCF, XPERIMENTAL EVIDENCE indicates that the nervous and immune hematopoietic systems can communicate bidirectionally via receptor-specific interactions by soluble mediators that include neuropeptides, cytokines, and neurotrophic factors.'.' These soluble mediators are produced by cells of the nervous, immune, and hematopoietic system~.'.~ The neuropeptide substance P (SP) is a mammalian undecapeptide that belongs to the tachykinin family. SP, widely distributed in the central and peripheral nervous systems' has been implicated in immune and hematopoietic modulation.8-'' Nerve fibers have direct synapse-like contacts with immune and hematopoietic cells present in primary and secondary lymphoid organ~.""~ Electron microscopic studies of the bone marrow (BM) indicate that nerve endings are in close contact with the cytoplasmic processes of the reticular and fibroblastoid ~e1ls.l~ Because these cells comprise subsets of BM stroma, this suggests that this BM cellular compartment may be in contact with nerve endings. In the thymus and secondary lymphoid organs, SP-immunoreactive (SP-IR) fibers have been found within the vasculature and in the parenchyma of these organ~.'~.'' Also, in the BM cavity, there are nerve fibers that stain positive for SP-IR. However, at present, the precise anatomical endings of SP-IR fibers in the BM is unknown.'3317 SP present in tissues can be derived from neural and/or nonneural sources. SP is synthesized in the cell body of neurons and transported axoplasmically for storage in the nerve terminals." Potential nonneural sources of SP in the We have reported that the adherent BM cell population (stroma) is partly responsible for in vitro hematopoietic stimulation by SP.8 Fibroblasts, endothelial cells, macrophages, reticular cells, and adipocytes3' compose the BM stroma and provide the necessary microenvironment for hematopoietic regulation.32"3 The mechanisms involved in this regulation are complex and appear to involve interactions between the stroma and progenitors/stem cells" mediated by cytokines, neurotrophic factors, and neuropeptide^.^^.^^ Previous studies from our laboratory suggested that the hematopoietic effects by SP are at least partly mediated by growth factors.' This is supported by studies indicating that SP can induce hematopoietic growth factors such as interleukin-l (IL-l)"x-4' and IL-638 in immune cells and IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in BM mononuclear cells. 42 Based on studies that implicate BM stroma and growth factors in SP-mediated hematopoietic modulation, we investigated the ability of SP to induce stem cell factor (SCF) and IL-I by SP in BM stroma. Both cytokines are stromaderived and can synergize with other cytokines to regulate h e m a t o p~i e s i s .~~-~~ Furthermore, IL-I appears to be a key element in hematopoietic and immune functions mediated by SP. This is supported by studies in our laboratory where we have shown that the induction of two hematopoietic growth factors (IL-3 and GM-CSF) by SP in BM cells is partly mediated by IL-l.42 Also, activation of T cells by SP requires this neuropeptide to induce the production of IL-l that, in turn, functions as a costimulus. 46 Experimental evidence suggests that cytokines and neurotrophic factors regulate expression of NK-R on hematopoi-NK-R.
BM are the macrophage^^^,'^ and eosinophils.2',22 The biologic effects of SP and other related tachykinins are mediated through interactions with G protein-coupled receptors of which three types have been cloned, neurokinin-1R (NKlR), NK-2R, and NK-3R.23324 Although subtypes of each of the NK-R have been ~uggested,'~ it is generally accepted that SP shows a preference for NK-1 and lesser affinities for NK-2 and NK-3.23. 24 The expression of SP-receptor has been reported on T and B macrophage^,'^^'^ CD34,29 and endothelial cells.3o Because these cells are involved in immune modulation and hematopoiesis, they are potential targets for SP in mediating immune functions and hematopoietic regulation.
We have reported that the adherent BM cell population (stroma) is partly responsible for in vitro hematopoietic stimulation by SP.8 Fibroblasts, endothelial cells, macrophages, reticular cells, and adipocytes3' compose the BM stroma and provide the necessary microenvironment for hematopoietic regulation.32"3 The mechanisms involved in this regulation are complex and appear to involve interactions between the stroma and progenitors/stem cells" mediated by cytokines, neurotrophic factors, and neuropeptide^.^^.^^ Previous studies from our laboratory suggested that the hematopoietic effects by SP are at least partly mediated by growth factors.' This is supported by studies indicating that SP can induce hematopoietic growth factors such as interleukin-l (IL-l)"x-4' and IL-638 in immune cells and IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in BM mononuclear cells. 42 Based on studies that implicate BM stroma and growth factors in SP-mediated hematopoietic modulation, we investigated the ability of SP to induce stem cell factor (SCF) and IL-I by SP in BM stroma. Both cytokines are stromaderived and can synergize with other cytokines to regulate h e m a t o p~i e s i s .~~-~~ Furthermore, IL-I appears to be a key element in hematopoietic and immune functions mediated by SP. This is supported by studies in our laboratory where we have shown that the induction of two hematopoietic growth factors (IL-3 and GM-CSF) by SP in BM cells is partly mediated by IL-l. 42 Also, activation of T cells by SP requires this neuropeptide to induce the production of IL-l that, in turn, functions as a costimulus. 46 Experimental evidence suggests that cytokines and neurotrophic factors regulate expression of NK-R on hematopoi-etic progenit~rs.~~ Previous reports with SP antagonists indicate that an NK-1 -type receptor is present in BM cell^.^-^^
In this study, we use ligand-binding studies and reverse transcriptase-polymerase chain reaction (RT-PCR) studies with NK-1R-specific primers to determine the ability of SCF and E-1 to modulate the expression and induction of NK-R in BM stroma. We found that SP induces the production of SCF and L-l and that these two cytokines not only increase an NK-l-like receptor mRNA in BM stroma but can also modulate their numbers and binding affinities. . SR 48968 and CP-96,345-1 were dissolved in dimethyl sulfoxide (Sigma, St Louis, MO) at 0.1 mom, aliquotted in siliconized tubes, and stored at -70°C. Immediately before use, the two nonpeptide antagonists were diluted in serum-free tissue culture medium. SP and spantide were dissolved in endotoxin-free distilled water, followed by solubilization of nitrogen, then were aliquoted in siliconized microcentrifuge tubes, and stored at -70°C. Reconstituted SP and spantide were used within 1 month.
MATERIALS AND METHODS

Reagents
Concanavalin A (Con A) and the following protease inhibitors, pepstatin, leupeptin and phenylmethylsulfonyl fluoride (PMSF), were purchased from Sigma.
Cytokines and antibodies. Recombinant human IL-la (rhIL-la) was kindly provided by Dr P. Lomedico (Hoffman-La Roche, Nutley, NJ); rhIL-lp and polyclonal rabbit anti-hIL-la and antih L -I p were purchased from Endogen (Boston, MA). Murine monoclonal anti-hIL-la and anti-IL-p were purchased from Collaborative Biomedical (Bedford, MA). Goat polyclonal anti-hSCF and rhSCF were purchased from R&D Systems (Minneapolis, MN). Murine monoclonal anti-hSCF was purchased from BioSource International (Camarillo, CA).
Animals. Male A M C r (6-to 8-weeks old) mice were purchased from the National Cancer Institute (Frederick Cancer Research Facility, Frederick, MD), and female Sprague-Dawley rats were purchased from Charles River (Wilmington, MA). All animals were maintained and handled in accordance to the guidelines of the Institutional Animal Care and Use Committee (New Jersey Medical School, Newark, NJ).
Cell lines. The D10.G4.1 cell line and K562 were purchased from the American Type Culture Collection (Rockville, MD). Maintenance of this cell line has been previously described." Briefly, cells were cultured in Click's medium (Irvine Scientific, Santa Ana, CA) containing supernatants obtained from rat spleen cells stimulated with Con A for 24 hours. Cells were expanded by activating with egg-white conalbumin (US Biochemicals, Cleveland, OH) in the context of gamma-irradiated LAk (AKR/NCr spleen) feeder cells.
Preparation of BM stroma. After we obtained informed consent, BM aspirates were taken from the posterior iliac crest of healthy volunteers and then were placed in preservative-free heparin. Cells (10 X lo6) were plated in 25-cm2 tissue culture flasks (Falcon 3109; Becton Dickinson, Lincoln Park, NJ) in culture media which consists of alpha-minimal essential media (GIBCO BRL, Grand Island, NY), 12.5% fetal calf sera (Hyclone Laboratories, Logan, UT) 12.5% horse serum (Hyclone Laboratories), 10" m o m hydrocortisone (Sigma), IOT4 m o m p-mercaptoethanol (Sigma), and 1.6 mmoY L glutamine (Cellgro; Mediatech, Herndon, VA). After 3 days of incubation at 3 7 T , to prevent the toxicity of eventual lysis by red blood cells, we separated the nonadherent mononuclear cells by Ficoll-Hypaque (Pharmacia LKB Biotechnology, Piscataway, NJ) density gradient and then replated them in fresh medium. Cells were reincubated until confluency was attained. This usually required 3 weeks of incubation. During this period, cultures were fed weekly by replacing 50% culture medium with fresh medium. Confluent flasks generally yield 7 X lo6 2 1 X ldcells (n = 10; no. of cells
SD).
Stimulation of BM strom for cytokine induction. Nonadherent cells were removed from confluent BM stroma, after which stroma was washed with endotoxin-free tissue culture grade phosphate-buffered saline (PBS) (Cellgro; Mediatech). After washing, 5 mL serumfree media was added to each flask. Serum-free medium contains alpha-minimal essential media plus serum supplement (GMS-A; GIBCO). Stromal cultures were stimulated with SP and either of the following antagonists: CP-96,345-1, SR 48968, or spantide. Samples to be assayed for cytokine protein levels were incubated for the optimum time period of 3 days, whereas mRNA induction was analyzed from stroma stimulated for l day. These specific incubation times were chosen based on cytokine induction in time course experiments ranging from day 1 to day 5 (data not shown).
Released cytokines were analyzed in the media, whereas cellassociated cytokine levels were assayed in homogenized stromal extracts. Media were concentrated one tenth of the original volume by lyophilization in a Savant Speed Vac Concentrator (Hicksville, NY). To obtain cell-associated cytokines, media were first removed, and 0.5 mL protease inhibitors (0.2 p m o m pepstatin, 5 pmoVL leupeptin, and 10 p m o m PMSF) was immediately added. Cells were scraped and then sonicated (Sonics Materials Inc, Danbury, CT). After sonication, cell-free fractions were obtained by centrifugation at 15,OOOg for 15 minutes and then frozen at -70°C until ready to be assayed for cytokine levels.
Northern analysis and cDNA probes. BM stroma was stimulated for 1 day as described above, and total RNA was extracted using the acid guanidium thiocyanate-phenol-chloroform extraction method as previously de~cribed.~' Total RNA (20 pg) was resuspended in denaturing conditions (formamideJformaldehyde) and electrophoresed on 1.2% agarose containing 4.8% formaldehyde and ethidium bromide. RNA ladders (0.24 to 9.5 kb and 0.16 to 1.77 kb) were used as molecular weight markers. RNA was transferred to nylon membranes (S & S Nytran, Keene, NH) overnight in lox sodium chloride/sodium citrate (SSC) buffer, then cross-linked with UV illumination, and baked for 2 hours at 80°C under vacuum. Membranes were prehybridized, followed by hybridization with cDNA probes for hIL-la, hIL-l/3, hSCF, and 28s. Probes were randomly labeled using the Prime-IT II random primer labeling kit (Stratagene, La Jolla, CA). After hybridization, membranes were washed twice at room temperature with 2X SSC buffer containing 0.1% sodium dodecyl sulfate (SDS), followed by 1 wash lasting 20 minutes at 37°C with buffer of similar stringency. Membranes were exposed to x-ray films and then developed by autoradiography. Hybridized membranes were stripped then rehybridized with each cDNA probe. Exposure time for autoradiography for IL-la, IL-16, SCF, and 28s ribosomal RNA (rRNA) were 3 days, 5 days, 5 days, and 4 hours, respectively. These exposures were based on the maximum time required for visualization of discreet mRNA signal. Ethidium bromide visualization of rRNA and/or hybridization with 28s
cDNA probe was used as loading controls and also for normalization.
Comparison of autoradiograms was performed by densitometric scanning.
Human cDNA probes for IL-la, IL-lp, and SCF were generously provided by Dr John M. Wozney (Genetics Institute, Cambridge, MA). The cDNA inserts for IL-la (1.7 kb), present in p m , and for IL-lP (1.3 kb), present in pSP64, were excised with Xho and Pst, respectively. SCF (0.6 kb) cDNA, inserted in EMC3 vector, For personal use only. on October 27, 2017. by guest www.bloodjournal.org From was excised at the Sal I-Xba I sites. cDNA probe (0.7 kb) for 28s rRNA was purchased from American Type Culture Collection (Rockville, MD) and was excised from pBluescript I1 SK(-) at EcoRI sites.
IL-l determination. IL-1 bioactivities and immunoreactivities in the supernatants as well as that associated with the stroma were quantitated in a proliferative assay with the murine T-helper clone (D10.G4.1 cell line) and enzyme-linked immunosorbent assay (ELISA), respectively. Bioactivities were based on the ability of supernatants to support the growth of Con A-stimulated D10.G4.1 cells as previously described?' Assays were performed with quiescent cells that were obtained from cultures that were stimulated with feeder cells 10 days before the date of assay. Supernatants (0.1 mL), in triplicate, were serially diluted in microtiter wells (Falcon 3072; Becton Dickinson). Diluent (assay medium) consisted of Click's medium containing 5% fetal calf sera and 2.5 pg/mL Con A. For each assay, a standard curve was established using serial dilutions of rhIL-la or rhIL-lp starting at 500 U/mL. Quiescent cells were resuspended in assay medium at 2 X 105/mL, and 0.1 mL was added to each well. After 65 hours, wells were pulsed for 4 hours with 1 pCi tritiated thymidine (['HITdR 2 Ci/mmol; New England Nuclear, Boston, MA). Cells were harvested onto glass fiber filter with a PHD cell harvester (Cambridge Technology, Watertown, MA), and ['HITdR incorporation was determined by liquid scintillation counting. One unit of IL-1 bioactivity was equivalent to half maximal ['HITdR incorporation of the D10.G4.1 cells in the standard curve.
ELlSA. SCF was quantitated using a sandwich ELISA as previously de~cribed.~' Goat polyclonal anti hSCF (4 pglmL) and murine monoclonal anti-hSCF (4 pg/mL) were used as capture and second antibodies, respectively. The capture antibody was diluted in Tris buffer (pH 8.9), whereas the second was diluted in PBS containing 1% bovine serum albumin (BSA; US Biochemicals). The second antibody was detected with biotinylated horse antimurine IgG (Vector Laboratories, Burlingame, CA), which was amplified with Avidin D (20 pg/mL; Vector Laboratories), followed by incubation with biotinylated conjugated alkaline phosphatase (0.2 U/mL; Vector Laboratories). Bound enzyme was detected with Sigma 104 phosphatase substrate dissolved in 0.5 mmoVL diethanolamine buffer containing 0.5 mmol/L magnesium chloride and 0.02% sodium azide (all reagents from Sigma). Color development was measured at a wavelength of 405 nm on an EL 311s microplate reader (Bio-Tek Instruments Inc, Winooski, VT).
The ELISA method for IL-1 is similar to that of SCF. Rabbit polyclonal anti-hIL-la and anti-hIL-lpl were used as capture antibodies, and murine monoclonal anti-hIL-la and anti-hIL-lp were used as second antibodies. The technique used for detecting IL-1 was also similarly performed with biotinylated horse antimurine IgG.
RT-PCR. The NK-1R-specific 25-mer oligo primers used in PCR were 5'-AGG ACA GTG ACG AAC TAT TTT CTG G-3'(sense) and 5'-CTG CTG GAT AAA CTT CTT CAG GTA G-3'(antisense). This primer pair corresponds to + 190 and +83 I on mRNA NK-1R sequences with a predicted amplification size of 0.6 kb based on the published cDNA sequence for the human NK-1R. 52 Control included PCR performed with random sequences of the primer pair. Oligonucleotides were synthesized by DNA Intemational Inc (Lake Oswego, OR).
Total RNA was extracted from BM stroma that was stimulated with SCF (25 ng/mL), rIL-la (25 ng/mL), or rIL-lp (25 ng/mL) for 1 day in serum-free medium (total volume, 5 mL) or from cells cultured for the same time period in serum-free medium alone. For first-strand synthesis, total RNA (1 pp) was reverse-transcribed using Moloney murine leukemia virus RT (MMLV-RT) with random hexamer (7 pmom) for 1 hour at 42°C (both purchased from Promega, Madison, WI). The reaction was terminated by incubating for 5 minutes at 99°C. The resulting product (cDNA) was used as template in PCR. Amplification was performed with 200 ng cDNA for 40 cycles with AmpliTaq (Perkin Elmer-Cetus, Nonvalk, CT) in a DNA thermal Cycler 480 (Perkin Elmer-Cetus). The profile for each cycle was as follows: linearization at 94°C for 1 minute, annealing of primers (7 pmol/L of each) at 65°C for 30 seconds, and extension at 72°C for 1 minute. Amplification products (25 pL) were resolved on 1.5% agarose containing ethidium bromide. Amplicon sizes were compared with l-kb DNA ladder and A DNAIHindIII fragments; both were obtained from GIBCO-BRL.
Binding assays. Nonadherent cells were removed from confluent BM stroma by washing (5 times) with serum-free medium. After washing, stroma were stimulated with either 25 ng/mL rhSCF or 25 ng/mL rhIL-la for 1, 3, and 5 days in 5 mL serum-free media. Control included stromal cells incubated in serum-free media alone for the same time period. Before the assay, stroma was washed (3 times) with PBS, pH 7.2, containing 1% BSA. Because the macrophage component of BM stroma is resistant to trypsin, to obtain all of the constituents, stromal layers were gently scraped with a cell scraper and then resuspended at 1 X 106/mL in binding medium containing PBS, 10% BSA, 0.1% sodium azide, 0.1 mmol/L PMSF, and 20 mmol/L HEPES (pH 7.4; Mediatech, Cellgro). To prevent absorption of SP, binding was performed in siliconized tubes.
Varying concentrations (3 to 200 nmol/L) of IZ5I-Tyr*-SP (2,200 Ci/mmol/L; New England Nuclear) were added to 1 mL BM stroma and resuspended at 1 X 106/mL. Binding was performed for 4 hours while rotating tubes at 4°C with a Rotating Wheel Two-way Mixer (Robbins Scientific, Sunnyvale, CA). After this period of incubation, cells were layered on 0.5 mL phthalate oils in siliconized microcentrifuge tubes and then centrifuged at 10,000g for 1 minute at 4°C. Phthalate oils consist of 90 parts dimethyl phthalate (Fischer Scientific, Pittsburgh, PA) and 10 parts phthalic acid dially ester (Sigma). The period of incubation (4 hours) falls within the range required for equilibrium that was established in time course binding assays ranging from 1 to 12 hours. The amount of bound and unbound ligand was determined by measuring the radioactivity in the pellet and supernatant fractions, respectively. Radioactivity was determined in a Beckman gamma counter (Beckman Instruments, Irvine, CA). 
RESULTS
Induction of SCF and IL-l in BM stroma by SP. We have reported that the adherent cell population is partly responsible for mediating the stimulatory hematopoietic effects by SP8. Because this cell population comprises the stroma and SP has the ability to induce hematopoietic growth fa~tors,3*-~* we investigated whether SP is capable of inducing SCF and IL-1 in BM stroma.
In three separate experiments, BM stroma was prepared to confluency and stimulated in serum-free medium with SP (lo-* m o m to 10"' mom) for 3 days. These concentrations
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were based on our previous studies which indicated that this range of SP exerted optimal hematopoietic effects in vitro.' Levels of immunoreactive SCF were determined in the supernatants (released cytokines) and in cell extracts (cellassociated cytokines). Optimal amounts of cell-associated SCF (K= 21 ? 2 ng/mL) were produced in BM stroma at m o m S P (Fig 1) . Regardless of stimulation, less than 0.02 ng/mL of SCF was detected in each of the supernatants that was concentrated one-tenth of the original volume. Because these levels were similar to cell-associated levels obtained from stroma cultured in media alone (Table l) , it was concluded that most of the SCF produced by SP in the stroma was cell-associated rather than being released in the culture media.
Bioactive IL-1 levels were determined in a proliferative assay using the IL-1-dependent D10.G4.1 T-helper clone. In our laboratory, we performed IL-1 assays with expanded cells taken from liquid nitrogen. We have found that the D10.G4.1 clone responded only to IL-1 if it is not passaged (unpublished observation). For cell-associated IL-l, the optimal levels were 83 ? 7 U/mL at m o a (Fig 1) . These data indicate that the optimal induction of cell-associated IL-1 and SCF require similar SP concentration.
Induction of IL-l and SCF in BM stroma by SP is mediated by an NK-l-type receptor. Although SP can bind to all three types of NK-Rs, the NK-3R appears to be present primarily in the central nervous system and in some nonimmune peripheral Therefore, we stimulated BM stroma with the optimal concentration of SP m o a ) in the presence of NK-l(CP-96,345-1), NK-2 (SR 48968), or a pan-tachykinin (spantide) receptor antagonists at concentrations ranging from lo-' to mol/L. On day 3 of stimulation, levels of SCF and IL-1 in cell-associated cultures were determined. For both cytokines, lo-' and lo-' m o m NK-1R-specific and pan-tachykinin antagonists BM stroma from 3 different normal healthy donors were stimulated for 3 days with lo-' mol/L SP in serum-free a-minimum essential medium in the presence or absence of each of the following antagonists (lo-' mol/L) NK-1R (CP-96, 345-l), NK-2R (SR 489681, or pantachykinin receptors (spantide). After stimulation, media were removed, and protease inhibitors (leupeptin, pepstatin, and PMSF) were added immediately. Cells were scraped and then sonicated, and ELISA used to determine cytokine levels in cell-free extracts. IL-l bioactivities were determined in a proliferative assay with the D10.G4.1 cells. Controls include cells cultured in serum-free media alone. All techniques are described in Materials and Methods. Data for each parameter are expressed as the mean 2 SD. Table 1 . The NK-2R antagonist was not responsible for the induction of IL-1 and SCF because cultures stimulated with lo-' to m o a NK-2R antagonist resulted in background levels (stroma cultured in media alone) of both cytokines (data not shown). These results indicate that SP-mediated induction of IL-1 and SCF in BM stroma is mediated by an NK-1-type receptor.
IL-10 is predominantly released in the culture media of BM stroma stimulated with SP. We found that SCF is not released in the media of SP-stimulated BM stroma. To determine if IL-1 is similarly associated with the stromal cells, we determined levels of bioactive IL-1 in supernatants concentrated one tenth of the original volume. In three separate experiments in which BM stroma was stimulated with m o m SP, we determined that 40 +-10 U/mL IL-1 was released (Table 2 ). This release was blocked by NK-1R antagonist and also by spantide, the pan-tachykinin antagonist (Table 2) . NK-2-specific antagonist was unable to block the release of IL-1 (Table 2) .
IL-1P represents the major isoform of this cytokine that is released, whereas IL-la appears to be mostly cell-associated. Because the bioassay does not discriminate the two isoforms of IL-l, we used ELISA to quantitate levels of IL-la and IL-10. We found that the levels of IL-l@ were twice the levels of IL-la ( Table 2) . These results indicate that, although less, IL-la as well as IL-lp are released from BM stroma on stimulation by SP.
Induction of SCF and IL-I mRNA in SP-stimulated BM stroma. Previous reports indicated that SCF is constituFor personal use only. on October 27, 2017. by guest www.bloodjournal.org From BM stroma from 3 different normal healthy donors were stimulated for 3 days with mol/L SP in serum-free u-minimum essential medium in the presence or absence of each of the following antagonists (lo-' mollL) NK-1R (CP-96,345-1), NK-PR (SR 48968), or pantachykinin receptors (spantide). Controls included cells cultured in serum-free media alone. After stimulation, media were collected, and residual cells were separated by centrifugation. Cell-free supernatants were concentrated to one tenth the original volume, then either assayed for bioactive IL-l in a proliferative assay with the D10.G4.1 cell line or assayed for immunoreactive IL-la and IL-lp by ELISA. All techniques are described in Materials and Methods. The data for each parameter are expressed as the mean t-SD.
tively expressed in BM stroma." We investigated whether the induction of SCF and IL-I protein correlated with an accumulation of their respective steady-state mRNA. This question was addressed by Northern analysis with RNA extracted from BM stroma stimulated with the optimal concentration of SP morn) for 24 hours in serum-free medium. To determine the specificity of SP-mediated effects, parallel cultures were performed with mol/L SP and lo-' molL of the following antagonists: CP-96.345-1, SR 48968, or spantide. In control cultures (medium alone), no band for the IL-I isoforms nor for SCF was visible (Fig 2,  lane 1) . For cultures stimulated with SP, densitometric analysis when normalized to the bands for 28s indicates 20-, IO-, and 30-fold increases in the SCF, IL-10, and IL-la mRNA, respectively, over control (Fig 2, lane 3) . RNA isolated from cultures with CP-96,345-1 (Fig 2, lane 2) and spantide (Fig 2, lane 4) resulted in bands that can be compared with controls. For cultures with SR 48968, the steadystate mRNA levels for all three cytokines were similar to those with SP alone (Fig 2, lane 5) . These results indicate that the induction of IL-l and SCF in BM stroma by SP correlates with an accumulation of their steady-state mRNA.
SP binding kinetics on BM stroma. Studies with antagonists indicate that SP-mediated induction of IL-I and SCF is specific ( Table 1) . To confirm that SP is capable of binding to BM stroma and also to determine the binding kinetics of SP on BM stroma, we performed ligand-binding studies with "'I-Tyr-SP. Because we observed that cytokines and neurotrophic factors can modulate the expression of SP-R in CD34' cells,29 we addressed the possibility that IL-1 and SCF may also exert similar effects in BM stroma. Cells were stimulated with IL-la, IL-10, and SCF, and ligand-binding studies performed on days 1, 3, and 5. We observed an initial downregulation of SP-binding sites followed by an upregulation on day 3 for both IL-la and SCF-stimulated cultures (Fig 3) . The results obtained with IL-10 were similar to IL-la (results with IL-10 not shown). The dissociation constants (h) for unstimulated cells at time 0 and days 1 and 5 are similar (0.9 nmol/L; see Fig 3A) . After stimulation by either cytokine at day 1, there was not only a downregulation of the total number of SP binding sites but also the appearance of an additional high-affinity receptor with the following dissociation constants: IL-la, 80 nmoVL; and SCF, 82 nmol/L. By days 3 and 5, the binding affinity of the receptors in stimulated cells was similar to unstimulated cells (Fig 3B for days; data for day 5 not shown) . The total number of SP-binding sites at day 3 was greater than that at day 1 ( Figs 3A and 3B) . Parallel binding experiments with excess cold SP reduced the binding of radiolabeled SP by 85% to 95%. Binding studies performed by day 5 resulted in receptor sites similar to unstimulated cells. These studies indicate that IL-I and SCF regulate the expression of SPbinding sites in BM stroma.
Amplification of NK-l-type receptor in SCF and IL-lstimulated BM stroma. Ligand-binding studies indicate that the number of SP-binding sites as well as the dissociation constants in BM stromal cells vary based on the exposure time to IL-I and SCF (Fig 3) . The induction of IL-I and SCF by SP in BM stroma is mediated by an NK-l-type receptor (Table l) . To study if NK-IR mRNA accumulates in BM stroma in response to these two cytokines, we used RT-PCR with specific NK-IR primers to determine if the size of the region spanning the primer pair is similar to published human sequences.s2 Because SP-binding sites are present in matured BM progenitor^,^' we determined whether the population of BM stroma used in RT-PCR contains contaminating myeloid precursors. We could not use the CD34 antigen to verify the presence of contaminating progenitors, because stromal cells have been reported to express this antigen. 58 We performed histochemical studies on BM stromal cells used in our assays. Our results indicate that cells stained negative for myeloperoxidase and chloroacetate esterase, indicating a lack of myeloid lineage. However, most of the cells stained positive for nonspecific esterase (85% ? 3%) implying the presence of macrophage histiocytic cell lineage, consistent with cells expected to constitute our in vitro BM stroma.
Ethidium bromide staining of RT-PCR products from unstimulated cells showed no visible bands (Fig 4A, lane 1,  and Fig 4B, lane 1) . However, cells stimulated with SCF (Fig 4A, lane 2) , IL-la (Fig 4A, lane 4) , and IL-1P ( Fig   4B, lane 2) resulted in strong bands at approximately 0.6 kb. Although we have purified the PCR products, weaker bands that are slightly larger than the predicted size of 0.6 kb are also observed in the stimulated cultures (Fig 4A, lanes   2 and 4; Fig 4B, lane 2) . These larger amplicons are more noticable in the L-la-stimulated (Fig 4A, lane 4) and IL-1/3-stimulated (Fig 4B, lane 2) cultures compared with those stimulated with SCF (Fig 4A, lane 2) . Random sequences of the NK-1 primers did not amplify any visible band in stimulated cultures (Fig 4A, lanes 3 and 5 ; Fig 4B, lane 3) . These data suggest that NK-1 mRNA is being induced in BM stroma by L -1 and SCF. The data also indicate that the sequences of the NK-1R mRNA in these cells might be different than the sequences found in other cloned human NK-1R cDNA.~'
DISCUSSION
The neuropeptide SP is a well studied neuromodulator of immune functions."." We have been studying the effects of this neuropeptide in the regulation of hematopoiesis assuming that the presence of SP in the BM microenvironment can be derived from neural and nonneural sources in physiological conditions. Endothelial cells and macrophages, cells that comprise the stroma, are potential nonneural sources for SP.19*20*59*60 Cytokines localized within the BM cavity and SP can regulate the production of each other." For example, it has been reported that leukemia-inhibitory factor (LIF) and IL-1 can regulate the transcription of the SP Nerve endings within the BM cavity are capable of retrogradely taking up IL-1,63 which in turn can modulate SP induction. If this is extrapolated to the BM microenvironment, it is possible to have a self-sustained system composed of the BM stroma and nerve endings communicating among themselves through cytokines and neuromodulators (Fig 5) .
We reported that the adherent BM cells are important in SP-mediated hematopoietic effects.* In other studies, SP has been shown to exert mitogenic functions on fibroblasts and endothelial cells similar to those that comprise the BM stroma.I0 The induction of two hematopoietic growth factors, SCF and IL-1 (Figs 1 and 2) , further supports the significance of the stroma in SP-mediated hematopoietic effects. IL-1 can induce a variety of other growth factors that have direct regulatory functions on hematopoietic progenitors, but also can have protective functional role on stem cells.M The latter function of IL-1 is particularly important when one considers that SCF is stimulatory to early progenitors. A recent report which indicated that IL-1 and SCF synergize in radioprot e~t i n g~~ suggests a potential indirect radioprotective function for SP. Time course and kinetic experiments indicated that the optimal induction of both IL-1 and SCF required a similar period of stimulation (data not shown) and similar SP concentration (Fig 1) . Studies have indicated that constitutive expression of SCF in human BM stroma is not regulated by IL-la?' and others indicated that IL-10 can induce SCF in stroma.@ SP-mediated upregulation of IL-1 and SCF in stroma, both at the level of the protein and mRNA could very well be independent of each other. Unlike IL-1, we could not detect significant amounts of SCF protein in the For personal use only. on October 27, 2017. by guest www.bloodjournal.org From culture supernatants, indicating that the form of SCF induced by SP is anchored onto the stromal cells. This is plausible because alternative splicing of transcripts from the human SCF gene can result in different i s o f o r m~.~' .~~ Although IL-la is considered a membrane-bound cytokine, we were able to detect this isoform of IL-l in the culture medium in SP-stimulated cultures ( Table 2 ). The significance of its release. although twofold less than that of IL-ID, is uncertain at this time. IL-I is capable of autoregulating the induction of other cytokines.M Its release could be capable of regulating NK-R in progenitor cells, similar to that in our previous studies which have shown that 1L-l is capable of regulating SP-binding sites on CD34' cells.'" IL-1 released in the supernatant can induce other hematopoietic growth factors. For example, we have shown that 1L-l indirectly induces the production of GM-CSF and IL-3 in SPstimulated BM mononuclear cells."
Amplification of cDNA from stromal cells with specific of an NK-Itype receptor, studies performed in this report indicate that the BM stroma may be expressing different subtypes of neurokinin receptors. This is illustrated in RT-PCR, where we have shown that a proportion of the products was slightly bigger than the predicted size ( Figs 4A and 4B) . Also, ligandbinding studies indicated that high-affinity NK-R can be induced by IL-I and SCF (Fig 3A) . Furthermore, the dissociation constant of the NK-R observed after stimulation with IL-I and SCF are different from those previously reported." Because a recent report indicated that monocytes express a G-protein-coupled nonneurokinin receptor,'" further characterization of SP receptor on BM stroma is necessary.
Induction of the high-affinity SP-binding sites, although in low numbers compared with those of the low-affinity receptor (Fig 3A) . could be significant in the immediate SP topoiesis by SP. BM stroma is innervated by peptid-Bone marrow ergic fibers. Release of SP, a neuropeptide, interacts stroma with specific receptor expressed on the stroma and induces the production of cytokines (e.g. IL-l and SCF). These growth factors in turn modulate the expression and induction of SP receptors. Cytokines
Modulation of SP receptors
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From response of BM stroma by L-1 and SCF stimulation. Because these two cytokines are themselves induced by SP in BM stroma (Fig 1 and Tables 1 and 2) , it is possible that there is a "fine-tuned" autoregulation by them to modulate NK-R. Cytokine production could be the mechanism by which the effects of SP on hematopoiesis are regulated (Fig   5) . Further studies regarding the types of neurokinin receptors present on specific stromal cell populations as well as the mechanisms in which they are regulated may provide new insight into one arm of the neurohematopoietic connection. The other is the retrograde uptake of cytokines to regulate transcription of the preprotackykinin A gene.
